Skip to main content

Table 1 Characteristics of the study subjects

From: Proteomics analysis of plasma protein changes in patent ductus arteriosus patients

 

Groups

No.

Boy

Girl

Age (month)

Weight (kg)

iTRAQ

Controls

4

2 (50%)

2 (50%)

27.3 ± 7.5

11.3 ± 1.3

 

PDA

4

2 (50%)

2 (50%)

29.5 ± 9.8

11.3 ± 2.3

ELISA

Controls

96

34 (35.4%)

62 (64.6%)

24.9 ± 27.1

10.7 ± 4.3

 

PDA

96

35 (36.5%)

61 (63.5%)

24.1 ± 25.6

10.4 ± 5.7

  1. iTRAQ Isobaric tag for relative and absolute quantitation; ELISA Enzyme-linked immunosorbent assay; PDA Patent ductus arteriosus
  2. N (%), mean ± standard deviation